EVENTS

ZeClinics is speaking at JSOT 2022!

49th Annual Meeting of the Japanese Society of Toxicology

EVENTS

ZeClinics is partnering in the BIO International Convention 2022

San Diego, California. European Pavilion, Booth 1911.

EVENTS

We are speaking at SLAS Europe 2022!

Society for Laboratory Automation and Screening Europe 2022 Conference & Exhibition, Dublin.

ZECLINICS NEWS

ZeClinics partners with the Institut de la Vision to test in zebrafish the most cutting-edge genome editing technologies

MEDIA

ZeClinics se asocia con el Institut de la Vision de París para testar en peces cebra las tecnologías de edición genómica más punteras

ZeClinics ha iniciado una colaboración con el investigador Filippo del Bene para desarrollar enfoques innovadores que permitan realizar modificaciones genéticas complejas

MEDIA

Un caso de estudio perfecto de la alianza exitosa entre CRO y Pharma

ZeClinics y Dompé Farmaceutici iniciaron esta colaboración hace unos años, en un esfuerzo por validar el uso del pez cebra para modelar de forma fiable las retinopatías humanas

Reducing-data-heterogeneity-with-ontologies. ZECLINICS NEWS

New article publication by ZeClinics and the SEAZIT program from the National Institute of Health

new-article-publication-by-ZeClinics-and-Dompé ZECLINICS NEWS

New article publication by ZeClinics and Dompé Farmaceutici

ZECLINICS NEWS

ZeClinics reached hire 20% of its workforce in 2021

MEDIA

ZeClinics objetivo 2022: Expandir el mercado en USA y mantener el crecimiento

La compañía busca incrementar su presencia en Estados Unidos

School on Genome Editing for Neuroscience Research ZECLINICS NEWS

Our scientific director will participate in teaching a school on genome editing for neuroscience research in Ghana, Africa

ZECLINICS NEWS

Filippo Del Bene, new member of ZeClinics’ Scientific Advisory Board

EVENTS

10th BioSpain International Trade show & Partnering

ZeClinics is participating in the current BioSpain edition.

EVENTS

Australasian College of Toxicology and Risk Assessment’s (ACTRA) Annual Scientific Meeting 2021

ZeClinics will contribute to the ACTRA Annual Scientific Meeting with an oral presentation of our Co-founder and CDD Javier Terriente

agreement-industrial-PhD ZECLINICS NEWS

ZeClinics and University of Messina enter into agreement to launch a joint Industrial PhD Program in Veterinary Sciences

EVENTS

Annual Meeting of the Japanese Society of Toxicology (JSOT)

ZeClinincs will attend the meeting to present its work on standardization of developmental neurotoxicity assessment.